A Case of Salivary Duct Carcinoma in the Submandibular Gland Treated Long-term with a Combination of Trastuzumab and Docetaxel-Reference-Cited by-同舟云学术

A Case of Salivary Duct Carcinoma in the Submandibular Gland Treated Long-term with a Combination of Trastuzumab and Docetaxel

Published:2018 Issue:0 Volume:152 Page:90-91
ISSN:0912-1870
Container-title:Practica oto-rhino-laryngologica. Suppl.
language:en
Short-container-title:Pract.Otol.(Kyoto)

Author:

Yabuuchi Saki¹²,Takebayashi Shinji¹³,Nakahira Mai¹,Tanigami Yuki¹,Hayashi Yasuyuki¹,Yasumoto Akiyoshi¹⁴,Gyo Kumiko¹,Hiwatashi Nao⁵,Ono Satoshi¹⁴,Ikeda Hiroki¹⁶,Ikegami Satoshi²,Miura Makoto¹

Affiliation:

1. Department of Otolaryngology, Japanese Red Cross Wakayama Medical Center

2. Department of Otolaryngology, Head and Neck Surgery, Shizuoka Municipal Hospital

3. Department of Otolaryngology, Kobe City Medical Center General Hospital

4. Department of Otolaryngology, Head and Neck Surgery, Kokura Memorial Hospital

5. Department of Otolaryngology, Head and Neck Surgery, Kyoto University Graduate School of Medicine

6. Ikeda Ear, Nose and Throat Clinic

Publisher

The Society of Practical Otolaryngology

Subject

Otorhinolaryngology

Link

https://www.jstage.jst.go.jp/article/jibirinsuppl/152/0/152_90/_pdf

Reference23 articles.

1. 1) Seifert G : Diagnosis and prognosis of salivary gland tumors. An interpretation of new revised WHO classification. Mund Kiefer Gesichtschir 1: 252–267, 1997.

2. 2) Jaehne M, Roeser K, Jaekel T, et al. : Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Cancer 103: 2526–2533, 2005.

3. 3) Hosal AS, Fan C, Barnes L, et al. : Salivary duct carcinoma. Otolaryngol Head Neck Surg 129: 720–725, 2003.

4. 4) Sato N, Sano M, Tabei T, et al. : Combination docetaxel and trastuzumab treatment for patients with HER-2-overexpressing metastatic breast cancer: a multicenter, phase-II study. Breast Cancer 13: 166–171, 2006.

5. 5) Wolff AC, Hammond ME, Schwartz JN, et al. : American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 131: 18–43, 2007.